This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
Comparison of two different Extended depth of focus intraocular lenses
OMIQ Research
Sant Cugat del Vallès, Barcelona, Spain
RECRUITINGDistance-corrected binocular defocus curve at 4 m
Time frame: 3 months
Monocular and binocular, corrected and uncorrected distance, intermediate, and near visual acuities
Visual acuities in logMAR scale using ETDRS (Early Treatment Diabetic Retinopathy Study) charts
Time frame: 3 months
Distance-corrected contrast sensitivity
Contrast sensitivity using M\&S device
Time frame: Three months
Low contrast (25%) binocular distance-corrected visual acuity
Contrast sensitivity in logMAR scale using low contrast ETDRS (Early Treatment Diabetic Retinopathy Study) charts
Time frame: 3 months
Visual dysfunction assessment using the QUVID (Questionnaire for visual disturbances) questionnaire
Assessment of qualitative visual dysphotopsia using a specific validated questionnaire
Time frame: 3 months
Spectacle independence assessment using the IOLSAT (Intraocular lens satisfaction) questionnaire
Assessment of recent use of spectacles to see at different distances using a specific questionnaire
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.